2017 Q3 Form 10-K Financial Statement

#000072312517000131 Filed on October 26, 2017

View on sec.gov

Income Statement

Concept 2017 Q3 2016 Q3 2016 Q2
Revenue $6.138B $3.217B $2.898B
YoY Change 90.8% -10.64% -24.79%
Cost Of Revenue $3.026B $2.638B $2.400B
YoY Change 14.71% 0.3% -9.47%
Gross Profit $3.112B $579.0M $498.0M
YoY Change 437.48% -40.31% -58.57%
Gross Profit Margin 50.7% 18.0% 17.18%
Selling, General & Admin $193.0M $157.0M $148.0M
YoY Change 22.93% -7.65% -12.43%
% of Gross Profit 6.2% 27.12% 29.72%
Research & Development $447.0M $411.0M $382.0M
YoY Change 8.76% 8.44% -5.91%
% of Gross Profit 14.36% 70.98% 76.71%
Depreciation & Amortization $1.066B $714.0M $725.0M
YoY Change 49.3% 0.56% 12.58%
% of Gross Profit 34.25% 123.32% 145.58%
Operating Expenses $637.0M $566.0M $530.0M
YoY Change 12.54% 4.24% -7.83%
Operating Profit $2.502B -$32.00M -$27.00M
YoY Change -7918.75% -107.49% -104.28%
Interest Expense -$144.0M -$137.0M $109.0M
YoY Change 5.11% 50.55% 12.37%
% of Operating Profit -5.76%
Other Income/Expense, Net $0.00 $1.000M -$34.00M
YoY Change -100.0% -94.74% 112.5%
Pretax Income $2.321B -$168.0M -$160.0M
YoY Change -1481.55% -147.32% -130.36%
Income Tax -$47.00M $3.000M $15.00M
% Of Pretax Income -2.02%
Net Earnings $2.368B -$170.0M -$215.0M
YoY Change -1492.94% -136.09% -143.79%
Net Earnings / Revenue 38.58% -5.28% -7.42%
Basic Earnings Per Share $2.13 -$0.16 -$0.21
Diluted Earnings Per Share $1.99 -$0.16 -$0.21
COMMON SHARES
Basic Shares Outstanding 1.036B shares
Diluted Shares Outstanding 1.036B shares

Balance Sheet

Concept 2017 Q3 2016 Q3 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.428B $4.398B $4.981B
YoY Change 23.42% 24.91% 2.49%
Cash & Equivalents $5.109B $4.140B $4.627B
Short-Term Investments $319.0M $258.0M $354.0M
Other Short-Term Assets $147.0M $140.0M $136.0M
YoY Change 5.0% -38.6% -42.62%
Inventory $3.123B $2.889B $2.920B
Prepaid Expenses
Receivables $3.490B $1.765B $1.752B
Other Receivables $169.0M $184.0M $306.0M
Total Short-Term Assets $12.46B $9.495B $10.11B
YoY Change 31.2% 10.46% 1.02%
LONG-TERM ASSETS
Property, Plant & Equipment $19.43B $14.69B $13.21B
YoY Change 32.31% 39.15% 34.01%
Goodwill $1.228B $104.0M
YoY Change 1080.77%
Intangibles $387.0M $464.0M $491.0M
YoY Change -16.59% 3.34%
Long-Term Investments $16.00M $1.364B $1.361B
YoY Change -98.83% -1.09% 2.79%
Other Assets $450.0M $356.0M $528.0M
YoY Change 26.4% -21.76% 7.1%
Total Long-Term Assets $22.88B $18.05B $16.89B
YoY Change 26.79% 16.07% 11.65%
TOTAL ASSETS
Total Short-Term Assets $12.46B $9.495B $10.11B
Total Long-Term Assets $22.88B $18.05B $16.89B
Total Assets $35.34B $27.54B $27.00B
YoY Change 28.31% 14.07% 7.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.333B $1.186B $1.105B
YoY Change 12.39% 16.27% 10.5%
Accrued Expenses $603.0M $289.0M $292.0M
YoY Change 108.65% -9.97% -14.12%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.262B $756.0M $712.0M
YoY Change 66.93% -30.58% -37.98%
Total Short-Term Liabilities $5.334B $4.835B $4.500B
YoY Change 10.32% 23.82% -1.45%
LONG-TERM LIABILITIES
Long-Term Debt $9.893B $9.154B $8.919B
YoY Change 8.07% 45.28% 38.26%
Other Long-Term Liabilities $639.0M $623.0M $548.0M
YoY Change 2.57% -10.74% -28.27%
Total Long-Term Liabilities $639.0M $623.0M $548.0M
YoY Change 2.57% -10.74% -28.27%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.334B $4.835B $4.500B
Total Long-Term Liabilities $639.0M $623.0M $548.0M
Total Liabilities $15.85B $14.61B $13.97B
YoY Change 8.44% 34.61% 19.04%
SHAREHOLDERS EQUITY
Retained Earnings $10.26B $5.299B $5.470B
YoY Change 93.62% -5.17% 6.9%
Common Stock $8.399B $7.845B $7.784B
YoY Change 7.06% 3.47% 3.29%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.029B
YoY Change 435.94%
Treasury Stock Shares 54.00M shares
Shareholders Equity $18.62B $12.08B $12.19B
YoY Change
Total Liabilities & Shareholders Equity $35.34B $27.54B $27.00B
YoY Change 28.31% 14.07% 7.42%

Cashflow Statement

Concept 2017 Q3 2016 Q3 2016 Q2
OPERATING ACTIVITIES
Net Income $2.368B -$170.0M -$215.0M
YoY Change -1492.94% -136.09% -143.79%
Depreciation, Depletion And Amortization $1.066B $714.0M $725.0M
YoY Change 49.3% 0.56% 12.58%
Cash From Operating Activities $3.203B $896.0M $389.0M
YoY Change 257.48% -13.01% -70.86%
INVESTING ACTIVITIES
Capital Expenditures -$1.265B -$1.923B -$1.685B
YoY Change -34.22% 8.95% 129.56%
Acquisitions
YoY Change
Other Investing Activities -$13.00M $497.0M $1.069B
YoY Change -102.62% 94.9% -236.01%
Cash From Investing Activities -$1.278B -$1.426B -$616.0M
YoY Change -10.38% -5.56% -59.47%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -858.0M 42.00M 1.771B
YoY Change -2142.86% -104.5% 393.31%
NET CHANGE
Cash From Operating Activities 3.203B 896.0M 389.0M
Cash From Investing Activities -1.278B -1.426B -616.0M
Cash From Financing Activities -858.0M 42.00M 1.771B
Net Change In Cash 1.067B -488.0M 1.544B
YoY Change -318.65% -65.46% 787.36%
FREE CASH FLOW
Cash From Operating Activities $3.203B $896.0M $389.0M
Capital Expenditures -$1.265B -$1.923B -$1.685B
Free Cash Flow $4.468B $2.819B $2.074B
YoY Change 58.5% 0.86% 0.24%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017 dei Amendment Flag
AmendmentFlag
false
CY2017 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--08-31
CY2017 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2017 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2017 dei Document Period End Date
DocumentPeriodEndDate
2017-08-31
CY2017 dei Document Type
DocumentType
10-K
CY2017 dei Entity Central Index Key
EntityCentralIndexKey
0000723125
CY2017Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1153255224 shares
CY2017 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2017 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2017Q1 dei Entity Public Float
EntityPublicFloat
20500000000 USD
CY2017 dei Entity Registrant Name
EntityRegistrantName
MICRON TECHNOLOGY INC
CY2017 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2017 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2016 mu Business Acquisition Pro Forma Net Income Loss Including Portion Attributableto Noncontrolling Interest
BusinessAcquisitionProFormaNetIncomeLossIncludingPortionAttributabletoNoncontrollingInterest
-543000000 USD
CY2017 mu Business Acquisition Pro Forma Net Income Loss Including Portion Attributableto Noncontrolling Interest
BusinessAcquisitionProFormaNetIncomeLossIncludingPortionAttributabletoNoncontrollingInterest
5172000000 USD
CY2015 mu Business Combination Consideration Transferred Settlement Of Receivables Payables With Acquiree Net
BusinessCombinationConsiderationTransferredSettlementOfReceivablesPayablesWithAcquireeNet
0 USD
CY2016 mu Business Combination Consideration Transferred Settlement Of Receivables Payables With Acquiree Net
BusinessCombinationConsiderationTransferredSettlementOfReceivablesPayablesWithAcquireeNet
0 USD
CY2017 mu Business Combination Consideration Transferred Settlement Of Receivables Payables With Acquiree Net
BusinessCombinationConsiderationTransferredSettlementOfReceivablesPayablesWithAcquireeNet
361000000 USD
CY2016Q3 mu Deferred Tax Assets Operating Loss And Tax Credit Carryforwards
DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwards
3014000000 USD
CY2017Q3 mu Deferred Tax Assets Operating Loss And Tax Credit Carryforwards
DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwards
3426000000 USD
CY2015 mu Depreciationand Amortizationof Intangible Assets
DepreciationandAmortizationofIntangibleAssets
2667000000 USD
CY2016 mu Depreciationand Amortizationof Intangible Assets
DepreciationandAmortizationofIntangibleAssets
2980000000 USD
CY2017 mu Depreciationand Amortizationof Intangible Assets
DepreciationandAmortizationofIntangibleAssets
3861000000 USD
CY2015 mu Dilutive Securities Equity Method Investment Dilutive Effects
DilutiveSecuritiesEquityMethodInvestmentDilutiveEffects
-3000000 USD
CY2016 mu Dilutive Securities Equity Method Investment Dilutive Effects
DilutiveSecuritiesEquityMethodInvestmentDilutiveEffects
0 USD
CY2017 mu Dilutive Securities Equity Method Investment Dilutive Effects
DilutiveSecuritiesEquityMethodInvestmentDilutiveEffects
0 USD
CY2016Q3 mu Equipment Purchase Payable Current
EquipmentPurchasePayableCurrent
1649000000 USD
CY2017Q3 mu Equipment Purchase Payable Current
EquipmentPurchasePayableCurrent
1018000000 USD
CY2015 mu Gains Losses On Extinguishment Of Debt And Derivative Gain Loss On Derivative Net
GainsLossesOnExtinguishmentOfDebtAndDerivativeGainLossOnDerivativeNet
-49000000 USD
CY2016 mu Gains Losses On Extinguishment Of Debt And Derivative Gain Loss On Derivative Net
GainsLossesOnExtinguishmentOfDebtAndDerivativeGainLossOnDerivativeNet
-4000000 USD
CY2017Q2 mu Gains Losses On Extinguishment Of Debt And Derivative Gain Loss On Derivative Net
GainsLossesOnExtinguishmentOfDebtAndDerivativeGainLossOnDerivativeNet
-61000000 USD
CY2017Q3 mu Gains Losses On Extinguishment Of Debt And Derivative Gain Loss On Derivative Net
GainsLossesOnExtinguishmentOfDebtAndDerivativeGainLossOnDerivativeNet
-37000000 USD
CY2017 mu Gains Losses On Extinguishment Of Debt And Derivative Gain Loss On Derivative Net
GainsLossesOnExtinguishmentOfDebtAndDerivativeGainLossOnDerivativeNet
-100000000 USD
CY2015 mu Option Indexed To Issuers Equity Settlement Effecton Shareholders Equity
OptionIndexedToIssuersEquitySettlementEffectonShareholdersEquity
0 USD
CY2016 mu Option Indexed To Issuers Equity Settlement Effecton Shareholders Equity
OptionIndexedToIssuersEquitySettlementEffectonShareholdersEquity
0 USD
CY2017 mu Option Indexed To Issuers Equity Settlement Effecton Shareholders Equity
OptionIndexedToIssuersEquitySettlementEffectonShareholdersEquity
-125000000 USD
CY2015 mu Other Other Nonoperating Income Expense
OtherOtherNonoperatingIncomeExpense
23000000 USD
CY2016 mu Other Other Nonoperating Income Expense
OtherOtherNonoperatingIncomeExpense
-26000000 USD
CY2017 mu Other Other Nonoperating Income Expense
OtherOtherNonoperatingIncomeExpense
-9000000 USD
CY2015 mu Other Other Operating Income Expense Net
OtherOtherOperatingIncomeExpenseNet
28000000 USD
CY2016 mu Other Other Operating Income Expense Net
OtherOtherOperatingIncomeExpenseNet
2000000 USD
CY2017 mu Other Other Operating Income Expense Net
OtherOtherOperatingIncomeExpenseNet
-5000000 USD
CY2015 mu Payments For Derivative And Hedge Investing Activities
PaymentsForDerivativeAndHedgeInvestingActivities
132000000 USD
CY2016 mu Payments For Derivative And Hedge Investing Activities
PaymentsForDerivativeAndHedgeInvestingActivities
152000000 USD
CY2017 mu Payments For Derivative And Hedge Investing Activities
PaymentsForDerivativeAndHedgeInvestingActivities
274000000 USD
CY2015 mu Payments On Equipment Purchase Contracts
PaymentsOnEquipmentPurchaseContracts
95000000 USD
CY2016 mu Payments On Equipment Purchase Contracts
PaymentsOnEquipmentPurchaseContracts
46000000 USD
CY2017 mu Payments On Equipment Purchase Contracts
PaymentsOnEquipmentPurchaseContracts
519000000 USD
CY2015 mu Proceeds For Derivative And Hedge Investing Activities
ProceedsForDerivativeAndHedgeInvestingActivities
56000000 USD
CY2016 mu Proceeds For Derivative And Hedge Investing Activities
ProceedsForDerivativeAndHedgeInvestingActivities
335000000 USD
CY2017 mu Proceeds For Derivative And Hedge Investing Activities
ProceedsForDerivativeAndHedgeInvestingActivities
184000000 USD
CY2015 mu Reclassification Adjustment For Convertible Debt In Mezzanine
ReclassificationAdjustmentForConvertibleDebtInMezzanine
-19000000 USD
CY2016 mu Reclassification Adjustment For Convertible Debt In Mezzanine
ReclassificationAdjustmentForConvertibleDebtInMezzanine
-49000000 USD
CY2017 mu Reclassification Adjustment For Convertible Debt In Mezzanine
ReclassificationAdjustmentForConvertibleDebtInMezzanine
21000000 USD
CY2017Q3 mu Shareholder Rights Agreement Beneficial Owner Status Trigger Percent
ShareholderRightsAgreementBeneficialOwnerStatusTriggerPercent
0.0499 pure
CY2017Q3 mu Shareholder Rights Agreement Beneficial Ownership Increase Trigger Percent
ShareholderRightsAgreementBeneficialOwnershipIncreaseTriggerPercent
0.5 pure
CY2017 mu Shareholder Rights Agreement Ownership Evaluation Period
ShareholderRightsAgreementOwnershipEvaluationPeriod
P3Y
CY2017Q3 mu Shareholder Rights Agreement Purchase Discount Rights Received Ratio
ShareholderRightsAgreementPurchaseDiscountRightsReceivedRatio
1 right_per_share
CY2017Q3 mu Total Basis Differences For Investments In Indefinitely Reinvested Foreign Subsidiaries
TotalBasisDifferencesForInvestmentsInIndefinitelyReinvestedForeignSubsidiaries
12910000000 USD
CY2016Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3879000000 USD
CY2017Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3664000000 USD
CY2016Q3 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
309000000 USD
CY2017Q3 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
350000000 USD
CY2016Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
273000000 USD
CY2017Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
0 USD
CY2016Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
1186000000 USD
CY2017Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
1333000000 USD
CY2016Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1765000000 USD
CY2017Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3490000000 USD
CY2016Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
18919000000 USD
CY2017Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
22102000000 USD
CY2016Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-35000000 USD
CY2017Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
29000000 USD
CY2016Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
7736000000 USD
CY2017Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
8287000000 USD
CY2015 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt Subsequent Adjustments
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments
691000000 USD
CY2016 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt Subsequent Adjustments
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments
38000000 USD
CY2017 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt Subsequent Adjustments
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments
33000000 USD
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
168000000 USD
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
191000000 USD
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
215000000 USD
CY2015 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
138000000 USD
CY2016 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
126000000 USD
CY2017 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
125000000 USD
CY2015 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
117000000 USD
CY2016 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
117000000 USD
CY2017 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
106000000 USD
CY2016Q3 us-gaap Assets
Assets
27540000000 USD
CY2017Q3 us-gaap Assets
Assets
35336000000 USD
CY2016Q3 us-gaap Assets Current
AssetsCurrent
9495000000 USD
CY2017Q3 us-gaap Assets Current
AssetsCurrent
12457000000 USD
CY2016Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
4812000000 USD
CY2017Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
6045000000 USD
CY2017Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
0 USD
CY2016Q3 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
258000000 USD
CY2017Q3 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
319000000 USD
CY2016Q3 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
414000000 USD
CY2017Q3 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
617000000 USD
CY2016 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
-0.50
CY2017 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
4.68
CY2016 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
-0.50
CY2017 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
4.42
CY2016 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-544000000 USD
CY2017 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
5171000000 USD
CY2016 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
12341000000 USD
CY2017 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
20317000000 USD
CY2015 us-gaap Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain
BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
0 USD
CY2016 us-gaap Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain
BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
0 USD
CY2017 us-gaap Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain
BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
71000000 USD
CY2015 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
345000000 USD
CY2016 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
993000000 USD
CY2017 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
813000000 USD
CY2017Q3 us-gaap Capital Lease Obligations
CapitalLeaseObligations
1190000000 USD
CY2017Q3 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
402000000 USD
CY2017Q3 us-gaap Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
62000000 USD
CY2017Q3 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
97000000 USD
CY2017Q3 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
229000000 USD
CY2017Q3 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
334000000 USD
CY2017Q3 us-gaap Capital Leases Future Minimum Payments Due Thereafter
CapitalLeasesFutureMinimumPaymentsDueThereafter
227000000 USD
CY2017Q3 us-gaap Capital Leases Future Minimum Payments Interest Included In Payments
CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments
161000000 USD
CY2016Q3 us-gaap Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation
CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation
492000000 USD
CY2017Q3 us-gaap Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation
CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation
626000000 USD
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4140000000 USD
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5109000000 USD
CY2014Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4234000000 USD
CY2015Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2375000000 USD
CY2016Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4263000000 USD
CY2017Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5216000000 USD
CY2015 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1859000000 USD
CY2016 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1888000000 USD
CY2017 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
953000000 USD
CY2016Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2017Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2017Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2016Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1094000000 shares
CY2017Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1116000000 shares
CY2016Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1040000000 shares
CY2017Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1112000000 shares
CY2016Q3 us-gaap Common Stock Value
CommonStockValue
109000000 USD
CY2017Q3 us-gaap Common Stock Value
CommonStockValue
112000000 USD
CY2015 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2856000000 USD
CY2016 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-324000000 USD
CY2017 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5153000000 USD
CY2015 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-1000000 USD
CY2016 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
1000000 USD
CY2017 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
1000000 USD
CY2015 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
2855000000 USD
CY2016 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-323000000 USD
CY2017 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
5154000000 USD
CY2015 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
10977000000 USD
CY2016 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9894000000 USD
CY2017 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
11886000000 USD
CY2015 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-6000000 USD
CY2016 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2017 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2015 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
93000000 USD
CY2016 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
27000000 USD
CY2017 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
152000000 USD
CY2015 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
88000000 USD
CY2016 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
28000000 USD
CY2017 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
153000000 USD
CY2015 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1000000 USD
CY2016 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1000000 USD
CY2017 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1000000 USD
CY2016Q3 us-gaap Customer Advances Current
CustomerAdvancesCurrent
132000000 USD
CY2017Q3 us-gaap Customer Advances Current
CustomerAdvancesCurrent
197000000 USD
CY2016Q3 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
9910000000 USD
CY2017Q3 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
11134000000 USD
CY2016Q3 us-gaap Debt Current
DebtCurrent
756000000 USD
CY2017Q3 us-gaap Debt Current
DebtCurrent
1262000000 USD
CY2016Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
10551000000 USD
CY2017Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
11639000000 USD
CY2015 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-15000000 USD
CY2016 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-39000000 USD
CY2017 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 USD
CY2015 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
85000000 USD
CY2016 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
32000000 USD
CY2017 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-39000000 USD
CY2016Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
657000000 USD
CY2017Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
766000000 USD
CY2016Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
535000000 USD
CY2017Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
712000000 USD
CY2016Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
200000000 USD
CY2017Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
408000000 USD
CY2015 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-1000000 USD
CY2016 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-2000000 USD
CY2017 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0 USD
CY2016Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
3297000000 USD
CY2017Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
3782000000 USD
CY2016Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
655000000 USD
CY2017Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
749000000 USD
CY2016Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1190000000 USD
CY2017Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1461000000 USD
CY2016Q3 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
65000000 USD
CY2017Q3 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
86000000 USD
CY2016Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
142000000 USD
CY2017Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
211000000 USD
CY2016Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
76000000 USD
CY2017Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
59000000 USD
CY2016Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2107000000 USD
CY2017Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2321000000 USD
CY2016Q3 us-gaap Deferred Tax Liabilities Financing Arrangements
DeferredTaxLiabilitiesFinancingArrangements
170000000 USD
CY2017Q3 us-gaap Deferred Tax Liabilities Financing Arrangements
DeferredTaxLiabilitiesFinancingArrangements
145000000 USD
CY2016Q3 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
81000000 USD
CY2017Q3 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
85000000 USD
CY2016Q3 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
28000000 USD
CY2017Q3 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
59000000 USD
CY2016Q3 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
135000000 USD
CY2017Q3 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
300000000 USD
CY2016Q3 us-gaap Deferred Tax Liabilities Undistributed Foreign Earnings
DeferredTaxLiabilitiesUndistributedForeignEarnings
121000000 USD
CY2017Q3 us-gaap Deferred Tax Liabilities Undistributed Foreign Earnings
DeferredTaxLiabilitiesUndistributedForeignEarnings
123000000 USD
CY2016Q3 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
167000000 USD
CY2017Q3 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
175000000 USD
CY2016Q3 us-gaap Defined Benefit Plan Fair Value Of Plan Assets
DefinedBenefitPlanFairValueOfPlanAssets
131000000 USD
CY2017Q3 us-gaap Defined Benefit Plan Fair Value Of Plan Assets
DefinedBenefitPlanFairValueOfPlanAssets
150000000 USD
CY2015 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
55000000 USD
CY2016 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
54000000 USD
CY2017 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
52000000 USD
CY2017 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.05 pure
CY2017 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.75 pure
CY2015 us-gaap Depreciation
Depreciation
2550000000 USD
CY2016 us-gaap Depreciation
Depreciation
2860000000 USD
CY2017 us-gaap Depreciation
Depreciation
3760000000 USD
CY2015 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.71
CY2015Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
CY2016Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
CY2016 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
CY2016Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
CY2017Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.81
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.49
CY2017Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.13
CY2017 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.67
CY2015 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.47
CY2015Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
CY2016Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
CY2016 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.27
CY2016Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2017Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.77
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.40
CY2017Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.99
CY2017 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.41
CY2015 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-133000000 USD
CY2016 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19000000 USD
CY2017 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-12000000 USD
CY2016Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
289000000 USD
CY2017Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
603000000 USD
CY2017Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
341000000 USD
CY2017 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y2M
CY2016Q3 us-gaap Equity Method Investment Summarized Financial Information Current Assets
EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
1222000000 USD
CY2017Q3 us-gaap Equity Method Investment Summarized Financial Information Current Assets
EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
107000000 USD
CY2016Q3 us-gaap Equity Method Investment Summarized Financial Information Current Liabilities
EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
604000000 USD
CY2017Q3 us-gaap Equity Method Investment Summarized Financial Information Current Liabilities
EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
19000000 USD
CY2015 us-gaap Equity Method Investment Summarized Financial Information Gross Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
1253000000 USD
CY2016 us-gaap Equity Method Investment Summarized Financial Information Gross Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
155000000 USD
CY2017 us-gaap Equity Method Investment Summarized Financial Information Gross Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
82000000 USD
CY2015 us-gaap Equity Method Investment Summarized Financial Information Income Loss From Continuing Operations Before Extraordinary Items
EquityMethodInvestmentSummarizedFinancialInformationIncomeLossFromContinuingOperationsBeforeExtraordinaryItems
1191000000 USD
CY2016 us-gaap Equity Method Investment Summarized Financial Information Income Loss From Continuing Operations Before Extraordinary Items
EquityMethodInvestmentSummarizedFinancialInformationIncomeLossFromContinuingOperationsBeforeExtraordinaryItems
199000000 USD
CY2017 us-gaap Equity Method Investment Summarized Financial Information Income Loss From Continuing Operations Before Extraordinary Items
EquityMethodInvestmentSummarizedFinancialInformationIncomeLossFromContinuingOperationsBeforeExtraordinaryItems
126000000 USD
CY2015 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
1361000000 USD
CY2016 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
184000000 USD
CY2017 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
76000000 USD
CY2016Q3 us-gaap Equity Method Investment Summarized Financial Information Noncurrent Assets
EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets
4294000000 USD
CY2017Q3 us-gaap Equity Method Investment Summarized Financial Information Noncurrent Assets
EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets
256000000 USD
CY2016Q3 us-gaap Equity Method Investment Summarized Financial Information Noncurrent Liabilities
EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities
411000000 USD
CY2017Q3 us-gaap Equity Method Investment Summarized Financial Information Noncurrent Liabilities
EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities
66000000 USD
CY2015 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
2647000000 USD
CY2016 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
1671000000 USD
CY2017 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
557000000 USD
CY2016Q3 us-gaap Equity Method Investments
EquityMethodInvestments
1364000000 USD
CY2017Q3 us-gaap Equity Method Investments
EquityMethodInvestments
16000000 USD
CY2016Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
402000000 USD
CY2017Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
477000000 USD
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
99000000 USD
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
17000000 USD
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
28000000 USD
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
33000000 USD
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
49000000 USD
CY2016Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
758000000 USD
CY2017Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
756000000 USD
CY2015 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-27000000 USD
CY2016 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-24000000 USD
CY2017 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-74000000 USD
CY2015 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
17000000 USD
CY2016 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
4000000 USD
CY2015 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-49000000 USD
CY2016 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-4000000 USD
CY2017 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
22000000 USD
CY2017 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-99000000 USD
CY2016Q3 us-gaap Goodwill
Goodwill
104000000 USD
CY2017Q3 us-gaap Goodwill
Goodwill
1228000000 USD
CY2015 us-gaap Gross Profit
GrossProfit
5215000000 USD
CY2015Q4 us-gaap Gross Profit
GrossProfit
849000000 USD
CY2016Q1 us-gaap Gross Profit
GrossProfit
579000000 USD
CY2016Q2 us-gaap Gross Profit
GrossProfit
498000000 USD
CY2016Q3 us-gaap Gross Profit
GrossProfit
579000000 USD
CY2016 us-gaap Gross Profit
GrossProfit
2505000000 USD
CY2016Q4 us-gaap Gross Profit
GrossProfit
1011000000 USD
CY2017Q1 us-gaap Gross Profit
GrossProfit
1704000000 USD
CY2017Q2 us-gaap Gross Profit
GrossProfit
2609000000 USD
CY2017Q3 us-gaap Gross Profit
GrossProfit
3112000000 USD
CY2017 us-gaap Gross Profit
GrossProfit
8436000000 USD
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
178000000 USD
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
72000000 USD
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-56000000 USD
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
2431000000 USD
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-353000000 USD
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
5252000000 USD
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2609000000 USD
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-281000000 USD
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
5196000000 USD
CY2015 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
447000000 USD
CY2016 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
25000000 USD
CY2017 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
8000000 USD
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
157000000 USD
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19000000 USD
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
114000000 USD
CY2015 us-gaap Income Tax Holiday Aggregate Dollar Amount
IncomeTaxHolidayAggregateDollarAmount
338000000 USD
CY2017 us-gaap Income Tax Holiday Aggregate Dollar Amount
IncomeTaxHolidayAggregateDollarAmount
742000000 USD
CY2015 us-gaap Income Tax Holiday Income Tax Benefits Per Share
IncomeTaxHolidayIncomeTaxBenefitsPerShare
0.29
CY2017 us-gaap Income Tax Holiday Income Tax Benefits Per Share
IncomeTaxHolidayIncomeTaxBenefitsPerShare
0.64
CY2015 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-260000000 USD
CY2016 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-63000000 USD
CY2017 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-64000000 USD
CY2015 us-gaap Income Tax Reconciliation Disposition Of Assets
IncomeTaxReconciliationDispositionOfAssets
-57000000 USD
CY2016 us-gaap Income Tax Reconciliation Disposition Of Assets
IncomeTaxReconciliationDispositionOfAssets
0 USD
CY2017 us-gaap Income Tax Reconciliation Disposition Of Assets
IncomeTaxReconciliationDispositionOfAssets
0 USD
CY2015 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-515000000 USD
CY2016 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
300000000 USD
CY2017 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-1571000000 USD
CY2015 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
913000000 USD
CY2016 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-98000000 USD
CY2017 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
1819000000 USD
CY2015 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
11000000 USD
CY2016 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-20000000 USD
CY2017 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
8000000 USD
CY2015 us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
118000000 USD
CY2016 us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
-52000000 USD
CY2017 us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
-12000000 USD
CY2015 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
53000000 USD
CY2016 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
48000000 USD
CY2016 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
272000000 USD
CY2017 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
66000000 USD
CY2015 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
63000000 USD
CY2016 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
90000000 USD
CY2017 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
99000000 USD
CY2016Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
119000000 USD
CY2017Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
100000000 USD
CY2015 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-691000000 USD
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
564000000 USD
CY2015 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-105000000 USD
CY2016 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-6000000 USD
CY2017 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
218000000 USD
CY2015 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-116000000 USD
CY2016 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
549000000 USD
CY2017 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-50000000 USD
CY2015 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-393000000 USD
CY2016 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-465000000 USD
CY2017 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
1651000000 USD
CY2016Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
866000000 USD
CY2017Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
864000000 USD
CY2016Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
464000000 USD
CY2017Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
387000000 USD
CY2015 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
20000000 USD
CY2016 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
43000000 USD
CY2017 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
7000000 USD
CY2015 us-gaap Interest Expense
InterestExpense
371000000 USD
CY2016 us-gaap Interest Expense
InterestExpense
437000000 USD
CY2017 us-gaap Interest Expense
InterestExpense
601000000 USD
CY2015 us-gaap Interest Paid Net
InterestPaidNet
226000000 USD
CY2016 us-gaap Interest Paid Net
InterestPaidNet
267000000 USD
CY2017 us-gaap Interest Paid Net
InterestPaidNet
468000000 USD
CY2016Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
899000000 USD
CY2017Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
856000000 USD
CY2016Q3 us-gaap Inventory Net
InventoryNet
2889000000 USD
CY2017Q3 us-gaap Inventory Net
InventoryNet
3123000000 USD
CY2016Q3 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
229000000 USD
CY2017Q3 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
299000000 USD
CY2016Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1761000000 USD
CY2017Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1968000000 USD
CY2015 us-gaap Investment Income Net
InvestmentIncomeNet
35000000 USD
CY2016 us-gaap Investment Income Net
InvestmentIncomeNet
42000000 USD
CY2017 us-gaap Investment Income Net
InvestmentIncomeNet
41000000 USD
CY2015 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
48000000 USD
CY2016 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
46000000 USD
CY2017 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
52000000 USD
CY2016Q3 us-gaap Liabilities
Liabilities
14612000000 USD
CY2017Q3 us-gaap Liabilities
Liabilities
15845000000 USD
CY2016Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
27540000000 USD
CY2017Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
35336000000 USD
CY2016Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4835000000 USD
CY2017Q3 us-gaap Liabilities Current
LiabilitiesCurrent
5334000000 USD
CY2016Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
9154000000 USD
CY2017Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
9872000000 USD
CY2016Q3 us-gaap Minority Interest
MinorityInterest
848000000 USD
CY2017Q3 us-gaap Minority Interest
MinorityInterest
849000000 USD
CY2015 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
6000000 USD
CY2016 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
34000000 USD
CY2016 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
93000000 USD
CY2015 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-718000000 USD
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1745000000 USD
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
349000000 USD
CY2015 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6216000000 USD
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3044000000 USD
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7537000000 USD
CY2015 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5208000000 USD
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3168000000 USD
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8153000000 USD
CY2015 us-gaap Net Income Loss
NetIncomeLoss
2899000000 USD
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
206000000 USD
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-97000000 USD
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-215000000 USD
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-170000000 USD
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-276000000 USD
CY2016Q4 us-gaap Net Income Loss
NetIncomeLoss
180000000 USD
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
894000000 USD
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
1647000000 USD
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
2368000000 USD
CY2017 us-gaap Net Income Loss
NetIncomeLoss
5089000000 USD
CY2015 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2016 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000000 USD
CY2017 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000000 USD
CY2015 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
2896000000 USD
CY2016 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-276000000 USD
CY2017 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
5089000000 USD
CY2015 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
142000000 USD
CY2016 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
37000000 USD
CY2017 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4 segment
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
2998000000 USD
CY2015Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
232000000 USD
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5000000 USD
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-27000000 USD
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-32000000 USD
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
168000000 USD
CY2016Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
359000000 USD
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1044000000 USD
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1963000000 USD
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2502000000 USD
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
5868000000 USD
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
154000000 USD
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
29000000 USD
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
17000000 USD
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
19000000 USD
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
23000000 USD
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
28000000 USD
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
38000000 USD
CY2017Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
12136000000 USD
CY2016Q3 us-gaap Other Assets Current
OtherAssetsCurrent
140000000 USD
CY2017Q3 us-gaap Other Assets Current
OtherAssetsCurrent
147000000 USD
CY2016Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
356000000 USD
CY2017Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
434000000 USD
CY2015 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-4000000 USD
CY2016 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
3000000 USD
CY2017 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
0 USD
CY2015 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-18000000 USD
CY2016 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
7000000 USD
CY2017 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
15000000 USD
CY2015 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-42000000 USD
CY2016 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-49000000 USD
CY2017 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
48000000 USD
CY2015 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-44000000 USD
CY2016 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-48000000 USD
CY2017 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
64000000 USD
CY2015 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-20000000 USD
CY2016 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
9000000 USD
CY2017 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-1000000 USD
CY2016Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
623000000 USD
CY2017Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
639000000 USD
CY2015 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-53000000 USD
CY2016 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-54000000 USD
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-112000000 USD
CY2015 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
21000000 USD
CY2016 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-15000000 USD
CY2017 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
22000000 USD
CY2015 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
45000000 USD
CY2016 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
6000000 USD
CY2017 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
17000000 USD
CY2016Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
184000000 USD
CY2017Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
169000000 USD
CY2015 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-25000000 USD
CY2016 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
74000000 USD
CY2017 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-190000000 USD
CY2015 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
4392000000 USD
CY2016 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
1026000000 USD
CY2017 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
1239000000 USD
CY2015 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2015 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
884000000 USD
CY2016 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
148000000 USD
CY2017 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
35000000 USD
CY2016 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2017 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
2634000000 USD
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4021000000 USD
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5817000000 USD
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4734000000 USD
CY2015 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
2212000000 USD
CY2016 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
2199000000 USD
CY2017 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
3311000000 USD
CY2015 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
13000000 USD
CY2016 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-203000000 USD
CY2017 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
8000000 USD
CY2015 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
2248000000 USD
CY2016 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
3690000000 USD
CY2017 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
970000000 USD
CY2015 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
1490000000 USD
CY2016 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
2310000000 USD
CY2017 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
776000000 USD
CY2015 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
74000000 USD
CY2016 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
48000000 USD
CY2017 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
142000000 USD
CY2015 us-gaap Profit Loss
ProfitLoss
2899000000 USD
CY2015Q4 us-gaap Profit Loss
ProfitLoss
206000000 USD
CY2016Q1 us-gaap Profit Loss
ProfitLoss
-96000000 USD
CY2016Q2 us-gaap Profit Loss
ProfitLoss
-215000000 USD
CY2016Q3 us-gaap Profit Loss
ProfitLoss
-170000000 USD
CY2016 us-gaap Profit Loss
ProfitLoss
-275000000 USD
CY2016Q4 us-gaap Profit Loss
ProfitLoss
180000000 USD
CY2017Q1 us-gaap Profit Loss
ProfitLoss
894000000 USD
CY2017Q2 us-gaap Profit Loss
ProfitLoss
1647000000 USD
CY2017Q3 us-gaap Profit Loss
ProfitLoss
2369000000 USD
CY2017 us-gaap Profit Loss
ProfitLoss
5090000000 USD
CY2016Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
33605000000 USD
CY2017Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
41533000000 USD
CY2016Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14686000000 USD
CY2017Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19431000000 USD
CY2016Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
2068000000 USD
CY2017Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
3759000000 USD
CY2015 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
2329000000 USD
CY2016 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
870000000 USD
CY2017 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
2558000000 USD
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1540000000 USD
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1617000000 USD
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1824000000 USD
CY2016Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
123000000 USD
CY2017Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
107000000 USD
CY2015 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
3000000 USD
CY2016 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
67000000 USD
CY2017 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
18000000 USD
CY2016Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
5299000000 USD
CY2017Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
10260000000 USD
CY2015 us-gaap Sale Leaseback Transaction Gross Proceeds Financing Activities
SaleLeasebackTransactionGrossProceedsFinancingActivities
291000000 USD
CY2016 us-gaap Sale Leaseback Transaction Gross Proceeds Financing Activities
SaleLeasebackTransactionGrossProceedsFinancingActivities
765000000 USD
CY2017 us-gaap Sale Leaseback Transaction Gross Proceeds Financing Activities
SaleLeasebackTransactionGrossProceedsFinancingActivities
0 USD
CY2015 us-gaap Sales Revenue Net
SalesRevenueNet
16192000000 USD
CY2015Q4 us-gaap Sales Revenue Net
SalesRevenueNet
3350000000 USD
CY2016Q1 us-gaap Sales Revenue Net
SalesRevenueNet
2934000000 USD
CY2016Q2 us-gaap Sales Revenue Net
SalesRevenueNet
2898000000 USD
CY2016Q3 us-gaap Sales Revenue Net
SalesRevenueNet
3217000000 USD
CY2016 us-gaap Sales Revenue Net
SalesRevenueNet
12399000000 USD
CY2016Q4 us-gaap Sales Revenue Net
SalesRevenueNet
3970000000 USD
CY2017Q1 us-gaap Sales Revenue Net
SalesRevenueNet
4648000000 USD
CY2017Q2 us-gaap Sales Revenue Net
SalesRevenueNet
5566000000 USD
CY2017Q3 us-gaap Sales Revenue Net
SalesRevenueNet
6138000000 USD
CY2017 us-gaap Sales Revenue Net
SalesRevenueNet
20322000000 USD
CY2015 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
719000000 USD
CY2016 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
659000000 USD
CY2017 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
743000000 USD
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
168000000 USD
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
191000000 USD
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
215000000 USD
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
101000000 shares
CY2017Q3 us-gaap Share Price
SharePrice
31.97
CY2017 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
995000000 USD
CY2015 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
74000000 USD
CY2016 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
48000000 USD
CY2017 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
142000000 USD
CY2015 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
53000000 USD
CY2016 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
23000000 USD
CY2017 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
35000000 USD
CY2016Q3 us-gaap Stockholders Equity
StockholdersEquity
12080000000 USD
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
18621000000 USD
CY2014Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11562000000 USD
CY2015Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
13239000000 USD
CY2016Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
12928000000 USD
CY2017Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
19470000000 USD
CY2017Q3 us-gaap Tax Credit Carryforward Amount
TaxCreditCarryforwardAmount
649000000 USD
CY2016Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
41000000 USD
CY2017Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
163000000 USD
CY2016Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 USD
CY2017Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
21000000 USD
CY2016Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
54000000 shares
CY2017Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
4000000 shares
CY2016Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1029000000 USD
CY2017Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
67000000 USD
CY2015 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
831000000 USD
CY2016 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
125000000 USD
CY2014Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
228000000 USD
CY2015Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
351000000 USD
CY2016Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
304000000 USD
CY2017Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
327000000 USD
CY2015 us-gaap Unrecognized Tax Benefits Decreases Resulting From Foreign Currency Translation
UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation
6000000 USD
CY2015 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
1000000 USD
CY2016 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
47000000 USD
CY2017 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
47000000 USD
CY2015 us-gaap Unrecognized Tax Benefits Increases Resulting From Acquisition
UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition
0 USD
CY2016 us-gaap Unrecognized Tax Benefits Increases Resulting From Acquisition
UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition
0 USD
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Acquisition
UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition
54000000 USD
CY2015 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
119000000 USD
CY2016 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
5000000 USD
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
15000000 USD
CY2016 us-gaap Unrecognized Tax Benefits Increases Resulting From Foreign Currency Translation
UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation
0 USD
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Foreign Currency Translation
UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation
2000000 USD
CY2015 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
17000000 USD
CY2016 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
0 USD
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
0 USD
CY2015 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
6000000 USD
CY2016 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
5000000 USD
CY2017 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
1000000 USD
CY2017Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
8000000 USD
CY2015 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
100000000 shares
CY2016 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2017 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
65000000 shares
CY2015 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1170000000 shares
CY2016 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1036000000 shares
CY2017 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1154000000 shares
CY2015 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1070000000 shares
CY2016 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1036000000 shares
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1089000000 shares
CY2017 us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Recently Issued Accounting Standards</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In October 2016, the FASB issued ASU 2016-16 &#8211; </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Intra-Entity Transfers Other Than Inventory</font><font style="font-family:inherit;font-size:10pt;">, which requires an entity to recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs. This ASU will be effective for us in the first quarter of 2019 with early adoption permitted and requires modified retrospective adoption. We are evaluating the timing and effects of our adoption of this ASU on our financial statements.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2016, the FASB issued ASU 2016-13 &#8211; </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Measurement of Credit Losses on Financial Instruments</font><font style="font-family:inherit;font-size:10pt;">, which requires a financial asset (or a group of financial assets) measured on the basis of amortized cost to be presented at the net amount expected to be collected. This ASU requires that the income statement reflect the measurement of credit losses for newly recognized financial assets as well as the expected increases or decreases of expected credit losses that have taken place during the period. This ASU requires that credit losses of debt securities designated as available-for-sale be recorded through an allowance for credit losses and limits the credit loss to the amount by which fair value is below amortized cost. This ASU will be effective for us in the first quarter of 2021 with adoption permitted as early as the first quarter of 2020. This ASU requires modified retrospective adoption, with prospective adoption for debt securities for which an other-than-temporary impairment had been recognized before the effective date. We are evaluating the timing and effects of our adoption of this ASU on our financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued ASU 2016-02 &#8211; </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases</font><font style="font-family:inherit;font-size:10pt;">, which amends a number of aspects of lease accounting, including requiring lessees to recognize operating leases with a term greater than one year on their balance sheet as a right-of- use asset and corresponding liability, measured at the present value of the lease payments. This ASU will be effective for us in the first quarter of 2020 with early adoption permitted and requires modified retrospective adoption. The adoption of this ASU will result in an increase to our consolidated balance sheets for these right-of-use assets and corresponding liabilities. We are evaluating the timing and other effects of our adoption of this ASU on our financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2016, the FASB issued ASU 2016-01 &#8211; </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Recognition and Measurement of Financial Assets and Financial Liabilities</font><font style="font-family:inherit;font-size:10pt;">, which provides guidance for the recognition, measurement, presentation, and disclosure of financial assets and liabilities. This ASU will be effective for us in the first quarter of 2019 and requires modified retrospective adoption. We are evaluating the effects of our adoption of this ASU on our financial statements.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the FASB issued ASU 2014-09 &#8211; </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers</font><font style="font-family:inherit;font-size:10pt;">, which supersedes nearly all existing revenue recognition guidance under generally accepted accounting principles in the United States. The core principal of this ASU, as amended, is that an entity should recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This ASU also requires additional disclosure about the nature, amount, timing, and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments, and assets recognized from costs incurred to obtain or fulfill a contract. We are required to adopt this ASU in the first quarter of 2019 with adoption permitted as early as the first quarter of 2018. This ASU allows for either full retrospective or modified retrospective adoption. We expect that, as a result of the adoption of this ASU, the timing of recognizing revenue from sales of products to our distributors under agreements allowing rights of return or price protection will be generally earlier than under the existing revenue recognition guidance. Revenue recognized upon resale by our customers under these arrangements was </font><font style="font-family:inherit;font-size:10pt;">20%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">25%</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">21%</font><font style="font-family:inherit;font-size:10pt;"> of our consolidated revenue for </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;">, respectively. After adoption, the impact of this change in any reporting period would be the net effect of changes to revenue recognized as of the beginning and end of each period. We are evaluating the timing, method, and other effects of our adoption of this ASU on our financial statements.</font></div></div>
CY2017 us-gaap Fiscal Period
FiscalPeriod
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our fiscal year is the 52 or 53-week period ending on the Thursday closest to August 31. Fiscal years 2017 and 2016 each contained 52 weeks and fiscal year 2015 contained 53 weeks. All period references are to our fiscal periods unless otherwise indicated.</font></div></div>
CY2017 us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Contingencies</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have accrued a liability and charged operations for the estimated costs of adjudication or settlement of various asserted and unasserted claims existing as of the balance sheet date, including those described below. We are currently a party to other legal actions arising from the normal course of business, none of which is expected to have a material adverse effect on our business, results of operations, or financial condition.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Patent Matters</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As is typical in the semiconductor and other high-tech industries, from time to time, others have asserted, and may in the future assert, that our products or manufacturing processes infringe upon their intellectual property rights.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On November 21, 2014, Elm 3DS Innovations, LLC ("Elm") filed a patent infringement action against Micron, MSP, and Micron Consumer Products Group, Inc. in the U.S. District Court for the District of Delaware. On March 27, 2015, Elm filed an amended complaint against the same entities. The amended complaint alleges that unspecified semiconductor products of ours that incorporate multiple stacked die infringe </font><font style="font-family:inherit;font-size:10pt;">thirteen</font><font style="font-family:inherit;font-size:10pt;"> U.S. patents and seeks damages, attorneys' fees, and costs.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 15, 2014, Innovative Memory Solutions, Inc. filed a patent infringement action against Micron in the U.S. District Court for the District of Delaware. The complaint alleges that a variety of our NAND products infringe </font><font style="font-family:inherit;font-size:10pt;">eight</font><font style="font-family:inherit;font-size:10pt;"> U.S. patents and seeks damages, attorneys' fees, and costs.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On June 24, 2016, the President and Fellows of Harvard University filed a patent infringement action against Micron in the U.S. District Court for the District of Massachusetts. The complaint alleges that a variety of our DRAM products infringe </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> U.S. patents and seeks damages, injunctive relief, and other unspecified relief.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Among other things, the above lawsuits pertain to certain of our DDR DRAM, DDR2 DRAM, DDR3 DRAM, DDR4 DRAM, SDR SDRAM, PSRAM, RLDRAM, LPDRAM, NAND, and certain other memory products we manufacture, which account for a significant portion of our net sales.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are unable to predict the outcome of assertions of infringement made against us and therefore cannot estimate the range of possible loss. A determination that our products or manufacturing processes infringe the intellectual property rights of others or entering into a license agreement covering such intellectual property could result in significant liability and/or require us to make material changes to our products and/or manufacturing processes. Any of the foregoing could have a material adverse effect on our business, results of operations, or financial condition.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Qimonda</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 20, 2011, Dr. Michael Jaff&#233;, administrator for Qimonda's insolvency proceedings, filed suit against Micron and Micron Semiconductor B.V., our Netherlands subsidiary ("Micron B.V."), in the District Court of Munich, Civil Chamber. The complaint seeks to void, under Section 133 of the German Insolvency Act, a share purchase agreement between Micron B.V. and Qimonda signed in fall 2008, pursuant to which Micron B.V. purchased substantially all of Qimonda's shares of Inotera (the "Inotera Shares"), representing approximately </font><font style="font-family:inherit;font-size:10pt;">18%</font><font style="font-family:inherit;font-size:10pt;"> of Inotera's outstanding shares as of </font><font style="font-family:inherit;font-size:10pt;">August&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, and seeks an order requiring us to re-transfer those shares to the Qimonda estate. The complaint also seeks, among other things, to recover damages for the alleged value of the joint venture relationship with Inotera and to terminate, under Sections 103 or 133 of the German Insolvency Code, a patent cross-license between us and Qimonda entered into at the same time as the share purchase agreement.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Following a series of hearings with pleadings, arguments, and witnesses on behalf of the Qimonda estate, on March 13, 2014, the court issued judgments:&#160;(1) ordering Micron B.V. to pay approximately </font><font style="font-family:inherit;font-size:10pt;">$1 million</font><font style="font-family:inherit;font-size:10pt;"> in respect of certain Inotera Shares sold in connection with the original share purchase; (2) ordering Micron B.V. to disclose certain information with respect to any Inotera Shares sold by it to third parties; (3) ordering Micron B.V. to disclose the benefits derived by it from ownership of the Inotera Shares, including in particular, any profits distributed on the Inotera Shares and all other benefits; (4) denying Qimonda's claims against Micron for any damages relating to the joint venture relationship with Inotera; and (5) determining that Qimonda's obligations under the patent cross-license agreement are canceled. In addition, the court issued interlocutory judgments ordering, among other things: (1) that Micron B.V. transfer to the Qimonda estate the Inotera Shares still owned by Micron B.V. and pay to the Qimonda estate compensation in an amount to be specified for any Inotera Shares sold to third parties; and (2) that Micron B.V. pay the Qimonda estate as compensation an amount to be specified for benefits derived by Micron B.V. from ownership of the Inotera Shares. The interlocutory judgments have no immediate, enforceable effect on us, and, accordingly, we expect to be able to continue to operate with full control of the Inotera Shares subject to further developments in the case. We have filed a notice of appeal, and the parties have submitted briefs to the appeals court.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are unable to predict the outcome of the matter and therefore cannot estimate the range of possible loss. The final resolution of this lawsuit could result in the loss of the Inotera Shares or monetary damages, unspecified damages based on the benefits derived by Micron B.V. from the ownership of the Inotera Shares, and/or the termination of the patent cross-license, which could have a material adverse effect on our business, results of operation, or financial condition.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Other</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the normal course of business, we are a party to a variety of agreements pursuant to which we may be obligated to indemnify the other party. It is not possible to predict the maximum potential amount of future payments under these types of agreements due to the conditional nature of our obligations and the unique facts and circumstances involved in each particular agreement. Historically, our payments under these types of agreements have not had a material adverse effect on our business, results of operations, or financial condition.</font></div></div>
CY2017 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain reclassifications have been made to prior period amounts to conform to current period presentation.</font></div></div>
CY2017 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates:</font><font style="font-family:inherit;font-size:10pt;"> The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires our management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, expenses, and related disclosures.&#160;Estimates and judgments are based on historical experience, forecasted events, and various other assumptions that we believe to be reasonable under the circumstances.&#160;Estimates and judgments may differ under different assumptions or conditions.&#160;We evaluate our estimates and judgments on an ongoing basis.&#160;Actual results could differ from estimates.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>

Files In Submission

Name View Source Status
0000723125-17-000131-index-headers.html Edgar Link pending
0000723125-17-000131-index.html Edgar Link pending
0000723125-17-000131.txt Edgar Link pending
0000723125-17-000131-xbrl.zip Edgar Link pending
a2013q4_chart-42352a02a07.jpg Edgar Link pending
a2017q4.htm Edgar Link pending
a2017q4ex10-69xsecondamend.htm Edgar Link pending
a2017q4ex10-70xexecutiveco.htm Edgar Link pending
a2017q4ex10-71xsecondamend.htm Edgar Link pending
a2017q4ex211-subsidiarieso.htm Edgar Link pending
a2017q4ex231-consentofinde.htm Edgar Link pending
a2017q4ex31-1xceocert.htm Edgar Link pending
a2017q4ex31-2xcfocert.htm Edgar Link pending
a2017q4ex32-1x906ceocert.htm Edgar Link pending
a2017q4ex32-2x906cfocert.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
mu-20170831.xml Edgar Link completed
mu-20170831.xsd Edgar Link pending
mu-20170831_cal.xml Edgar Link unprocessable
mu-20170831_def.xml Edgar Link unprocessable
mu-20170831_lab.xml Edgar Link unprocessable
mu-20170831_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R107.htm Edgar Link pending
R108.htm Edgar Link pending
R109.htm Edgar Link pending
R11.htm Edgar Link pending
R110.htm Edgar Link pending
R111.htm Edgar Link pending
R112.htm Edgar Link pending
R113.htm Edgar Link pending
R114.htm Edgar Link pending
R115.htm Edgar Link pending
R116.htm Edgar Link pending
R117.htm Edgar Link pending
R118.htm Edgar Link pending
R119.htm Edgar Link pending
R12.htm Edgar Link pending
R120.htm Edgar Link pending
R121.htm Edgar Link pending
R122.htm Edgar Link pending
R123.htm Edgar Link pending
R124.htm Edgar Link pending
R125.htm Edgar Link pending
R126.htm Edgar Link pending
R127.htm Edgar Link pending
R128.htm Edgar Link pending
R129.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending